Panthera Biopartners
Lynne Nicholson has had an extensive career in project management. Lynne began in 2003 as an Operations Associate at Wellness International Ltd. In 2006, they moved on to become a Clinical Project Manager at UK Biobank. From 2008 to 2017, they held the role of Global Project Manager at Synexus Limited, where they were responsible for leading internal multidisciplinary teams and establishing and managing excellent Client relationships. From 2017 to 2019, they were a Senior Project Manager, Operational and Strategic Support at Synexus Clinical Research Ltd, where they had line management responsibility of a small team of Clinical Project Managers. In 2020, they became a Senior Project Manager at UBC, and in 2021 they took on the same role at Panthera Biopartners.
Lynne Nicholson attended Ellesmere College from 1997 to 1999, where they earned A Levels in Business Studies, Physical Education and Art. Lynne then went on to Leeds Beckett University from 1999 to 2002, where they earned a BSc in Sport and Exercise Science.
This person is not in any offices
Panthera Biopartners
1 followers
Panthera Biopartners, established in 2019, is a leading UK-based Site Management Organisation (SMO) specialising in patient recruitment and the execution of clinical trials across various therapeutic areas. Founded by Dr Ian Smith, the originator of Synexus, and Professor John Lyon, a former global executive at Covance, Panthera has rapidly expanded its network to include dedicated clinical trial sites in major UK cities such as Glasgow, London, Manchester, Preston, Sheffield and York The organisation's mission is to enhance healthcare accessibility by conducting clinical research that integrates diverse insights and expertise. Panthera is committed to maintaining rigorous ethical standards and contributing to medical advancements that positively impact health and well-being. Panthera's management team comprises experienced professionals with extensive knowledge in conducting clinical trials across multiple therapy areas and countries. Key figures include Dr Ian Smith (Co-Founder, Director, and Chief Medical Officer), Stuart Young (Chief Executive Officer), and Chris Dodd (Chief Commercial Officer). In October 2024, Panthera became the first UK clinical trial site organisation to join Parexel’s Site Alliance Vaccine Network, a global consortium of high-performing clinical trial sites. This collaboration underscores Panthera's exceptional performance in patient recruitment and its strong partnership with Parexel. Panthera's dedication to innovation and excellence was recognised in October 2023 when it was named Pharma Research Centre of the Year at the Pharma Industry Awards UK. The award highlighted Panthera's innovative SMO model, which emphasises rapid start-up times, access to a vast pool of prequalified patients, and the digitisation of patient engagement processes.